| |
|
|
|
Monopar Therapeutics Inc  
|
|
5.27 0.24 (0.05%) |
09-17 16:00 |
|
Open: |
5.02 |
Pre close: |
5.03 |
Target:
|
7.05
|
|
High: |
5.3994 |
Low: |
4.8126 |
Resistance:
|
6.03
6.98
|
|
Volume: |
45,187 |
Market Cap: |
66M |
Support:
|
4.50
3.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.01
 |
MACD |
MACD(12,26):
|
0.01  |
|
MA(20): |
5.07 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
5.45 |
Stochastic Oscillator |
%K(14,3):
|
18.45 |
|
MA(250): |
5.83 |
%D(3): |
13.39 |
|
Average Volume(K) |
3-Month: |
93852
|
52-Week |
High:
|
17.01 |
|
10-Days: |
42007 |
Low: |
4.28 |
|
RSI |
RSI(14):
|
52.42 |
Change(%): |
-0.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.421 |
Return on Equity (ttm) |
-43.5 |
Shares Out. (M) |
12.57 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.5 |
Shares Float (M) |
4.28 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
66.06 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.48 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
63 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.52 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.89 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-2.93 |
P/CF |
-11.25 |
|
|
|
|
|
|
